Alzheimers Disease: – Evotec Successfully Completes Phase I for Potential Alzheimer’s …
Evotec Successfully Completes Phase I for Potential Alzheimer’s …
Yahoo! News (press release) - Aug 8, 2006… announced the successful completion of Phase I with EVT 101, an NR2B subtype-specific NMDA receptor antagonist for the treatment of Alzheimer’s disease and/or …
Rooftop fight against Alzheimer’s Disease
WHOI, IL - Aug 3, 2006More than four and a half million Americans have Alzheimer’s Disease, and doctors diagnose 350,000 new cases every year. For one …
Canadian actor, Dutch TV show win at Seoul Awards
China Post, Taiwan - 11 hours ago… China’s Lu Yuan was named best actress for her role in “Watch for the Happiness,” about a family that copes with a mother suffering from Alzheimer’s disease. …
Power3′s Biomarkers ‘Show Great Promise’ for Alzheimer’s …
Business Wire (press release), CA - Aug 30, 2006… that preliminary results of tests using biomarkers it discovered have shown greater than 90% sensitivity in identifying patients with Alzheimer’s disease. …
Related posts:
- Alzheimers Disease: – Memory Pharmaceuticals Completes Enrollment in Phase 2a MEM 1003 Alzheimer’s Disease Trial
- Alzheimers Disease: – Athenagen Initiates Phase II Clinical Trial in Alzheimer’s Disease
- Alzheimers Disease: – Potential New Treatment Strategy For Alzheimer’s Disease And Other …
- ANAVEX 2-73 advances Phase I clinical trial for Alzheimer’s disease
- Alzheimers Disease: – Potential problems of group vacation-home purchase